Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4172881000168119 | Tecentriq (atezolizumab 840 mg / 14 mL) injection, 14 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4172891000168116 | Tecentriq 840 mg/14 mL injection, 14 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | Tecentriq | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | atezolizumab 840 mg/14 mL injection, vial | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has unit of use | vial | true | Inferred relationship | Some | 682855197 | |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has intended active ingredient | atezolizumab | true | Inferred relationship | Some | 682855196 | |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has Australian BoSS | atezolizumab | true | Inferred relationship | Some | 682855196 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TPUU | True | Tecentriq 840 mg/14 mL injection, 14 mL vial | Inferred relationship | Some | 1 |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TPUU | True | Tecentriq 840 mg/14 mL injection, 14 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR